Amgen (AMGN)

Cost of Revenue

$10.43B

TTM · Period ending: · USD

AMGN logo

AMGN Cost of Revenue

Latest reported$10.43B
AMGN TTM Cost of Revenue ($0.00 → $10.43B)
High-resolution chart · PNG

AMGN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amgen Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
10,427,000,000
10,627,000,000
10,851,000,000
12,173,000,000
12,401,000,000
12,626,000,000
12,858,000,000
12,858,000,000
11,354,000,000
9,931,000,000
8,451,000,000
7,086,000,000
6,868,000,000
6,565,000,000
6,406,000,000
6,377,000,000
6,398,000,000
6,525,000,000
6,454,000,000
6,333,000,000
6,285,000,000
6,136,000,000
6,159,000,000
5,815,000,000
5,290,000,000
4,814,000,000
4,356,000,000
4,199,000,000
4,200,000,000
4,212,000,000
4,101,000,000
4,064,000,000
4,017,000,000
4,017,000,000
4,069,000,000
4,077,000,000
4,114,000,000
4,140,000,000
4,162,000,000
4,166,000,000
4,173,000,000
4,212,000,000
4,227,000,000
4,339,000,000
4,373,000,000
4,365,000,000
4,422,000,000
4,268,000,000
3,988,000,000
3,692,000,000
3,346,000,000
3,169,000,000
3,086,000,000
2,983,000,000
2,918,000,000
2,722,000,000
2,622,000,000
2,542,000,000
2,427,000,000
2,343,000,000
2,325,000,000
2,276,000,000
2,220,000,000
2,186,000,000
2,144,000,000
2,122,000,000
2,091,000,000
2,111,000,000
2,243,000,000
2,227,000,000
2,296,000,000
2,344,000,000
2,459,000,000
2,502,000,000
2,548,000,000
2,503,000,000
2,200,000,000
2,135,000,000
2,095,000,000
2,045,000,000
2,108,000,000
2,145,000,000
2,082,000,000
2,047,000,000
1,942,000,000
1,847,400,000
1,731,600,000
1,643,900,000
1,536,900,000
1,430,600,000
1,340,700,000
1,226,200,000
1,112,600,000
915,400,000
735,700,000
614,400,000
490,700,000
457,200,000
443,000,000
346,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.